Stay away from concomitant use of tucatinib with CYP3A substrates, the place minimal focus adjustments might bring about major or life-threatening toxicities. If unavoidable, reduce CYP3A substrate dose As outlined by item labeling.Medicines that need prior authorization. This restriction requires that certain medical conditions be fulfilled before